BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/29/2019 10:56:49 AM | Browse: 798 | Download: 1506
 |
Received |
|
2019-06-12 00:29 |
|
Peer-Review Started |
|
2019-06-19 09:51 |
|
To Make the First Decision |
|
2019-08-02 03:21 |
|
Return for Revision |
|
2019-08-05 01:37 |
|
Revised |
|
2019-09-08 03:41 |
|
Second Decision |
|
2019-09-10 14:46 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-09-11 06:09 |
|
Articles in Press |
|
2019-09-11 06:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-09-18 21:40 |
|
Typeset the Manuscript |
|
2019-09-24 07:35 |
|
Publish the Manuscript Online |
|
2019-09-29 10:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Case Report |
| Article Title |
Type I neurofibromatosis with spindle cell sarcoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yu Zhang, Jiao-Jiao Chao, Xiu-Feng Liu and Shu-Kui Qin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shu-Kui Qin, MD, Chief Doctor, Professor, Medical Oncology Department, PLA Cancer Center, Nanjing Bayi Hospital, Department of Oncology, the 81 Hospital of the Chinese People's Liberation Army, Nanjing 210002, PR China. qinsk@csco.org.cn., Nanjing 210002 Jiangsu Province, China. qinsk@csco.org.cn |
| Key Words |
Neurofibromatosis; Type I; Spindle cell sarcoma; Targeted therapy; Crizotinib; Case report |
| Core Tip |
Although neurofibromatosis type 1 with malignant tumor is very rare, it is still possible to occur. Because the disease is rare in clinical practice, there are many uncertainties in the selection of treatment regimens, so it is necessary to study the effective and reasonable standard treatment regimens. We present a case of Neurofibromatosis type 1 with soft tissue sarcoma. Since there is limited evidence of targeted therapy for this disease, the selection of treatment strategies should be based on rich clinical experience and research. |
| Publish Date |
2019-09-29 10:56 |
| Citation |
Zhang Y, Chao JJ, Liu XF, Qing SK. Type I neurofibromatosis with spindle cell sarcoma: A case report. World J Clin Cases 2019; 3104-3110 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i19/3104.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i19.3104 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
